As part of our program to develop PET tracers for investigating monoaminerg
ic processes in the brain, mianserin, a tetracyclic, atypical antidepressan
t, was selected as a candidate for labelling with C-11 for in vivo evaluati
on. [N-methyl-C-11]Mianserin was produced by the alkylation of N-desmethyl
mianserin with [C-11]methyl iodide followed by HPLC purification and formul
ation. [N-methyl-C-11]Mianserin was obtained with a radiochemical. purity >
93% in a 16% decay corrected radiochemical yield. For a typical production
starting with 40 GBq [C-11]CO2, 1.9 GBq [N-methyl-C-11]mianserin was obtain
ed as a formulated solution in a synthesis time of 35 min (counted from EOB
).